Gulf Pharmaceutical Industries P.S.C. (ADX: JULPHAR)

ADX: JULPHAR Revenue

Gulf Pharmaceutical Industries P.S.C. had revenue of 417.10M AED in the quarter ending September 30, 2024, with 13.96% growth. This brings the company's revenue in the last twelve months to 1.71B, up 7.91% year-over-year. In the year 2023, Gulf Pharmaceutical Industries P.S.C. had annual revenue of 1.64B with 1.36% growth.

• Revenue (ttm): 1.71B
• Revenue Growth: +7.91%
• P/S Ratio: 0.87
• Revenue / Employee: 713.67K
• Employees: 2,400
• Market Cap: 1.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.64B	21.90M	1.36%
Dec 31, 2022	1.62B	472.90M	41.37%
Dec 31, 2021	1.14B	570.20M	99.51%
Dec 31, 2020	573.00M	271.50M	90.05%
Dec 31, 2019	301.50M	-418.30M	-58.11%